The independent source for health policy research, polling, and news.
481 - 500 of 598 Results
Though Rep. Tom MacArthur (R-N.J.) counts himself a moderate, many of his voters heading to the polls are furious about how he aided his partyās efforts to dismantle Obamacare.
Many areas in the U.S. depend on foreign doctors, but bitter political arguments over immigration have sown concerns about limited opportunities for these physicians.
Republicans seek to turn the tables on charges that they are undermining preexisting conditions, so theyāre hammering the plans championed by some Democrats to expand Medicare.
Union-backed initiatives in Palo Alto and Livermore, Calif., aim to cap charges by hospitals and doctors, seeking to build on national furor over rising medical bills. The measures arise in health care markets that are among the most expensive in the nation.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donāt have to.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Idaho is one of four conservative states where voters next month will determine whether to buck the GOPās resistance to the Affordable Care Act and implement or renew its expansion of Medicaid to adults.
In this episode of KHNās āWhat the Health?ā Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss a flurry of proposals from the Trump administration on prices Medicare pays for drugs and the Affordable Care Act.
The state-federal health insurance program is more popular than ever. Now, states that want to expand eligibility are devising new strategies to pay for it ā creating, in many red states, a significant political challenge.
The front-runner in the California governorās race, known for his political audacity, has officially endorsed the controversial move to create one public insurance program for all Californians. Yet he also faces formidable challenges, and liberal critics fear heāll retreat.
This gap in the 2010 health law means health insurance remains unaffordable for millions of Americans. For now, relief is hard to come by.
Candidates are charging toward midterm elections on a platform of single-payer and universal coverage rhetoric. Yet āMedicare-for-allā and single-payer mean different things to different people.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donāt have to.
In this episode of KHNās āWhat the Health?ā Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Stephanie Armour of The Wall Street Journal and Joanne Kenen of Politico discuss how protections for people with preexisting conditions have become a top issue in the elections, Trump administration efforts to make prescription drug prices more public and the start of Medicareās annual open-enrollment period. Plus, Rovner interviews California Attorney General Xavier Becerra.
Californiaās 13 childrenās hospitals are asking voters in November to approve $1.5 billion in bonds to help them pay for construction and equipment, the third such measure in 14 years. Some health care experts and election analysts believe the repeated financial requests arenāt justified.
Nearly three-quarters of voters say that health care is the most important issue for them, but fewer than half are hearing much from candidates about it, according to a poll released by the Kaiser Family Foundation.
John Cox, Californiaās Republican candidate for governor, contends that policies on abortion, health insurance and health care access should be guided by the conservative ideals of free market competition and personal responsibility. He hasnāt offered specific policy positions on health care, except that government should largely stay out of it.
Drugmakers' contributions to lawmakers have peaked as surging drug prices emerge as a hot-button political issue. In the past decade, Congress has received nearly $79 million from 68 pharma PACs, run by employees of companies that make drugs treating everything from cancer to erectile dysfunction.
Drug pricing is a top issue in the run-up to the midterm elections.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donāt have to.
Ā© 2026 KFF